患者对使用口服皮质类固醇治疗喘的观点
Tonya Winders1, Monica Fletcher2, John Oppenheimer3
1Global Allergy & Airways Patient Platform, Vienna, Austria.
概括
使用口服皮质类固醇 (OCS) 治疗喘的患者报告了显著的不良事件,如体重增加和情绪变化,影响日常生活和坚持. 医疗保健提供者应与患者讨论OCS风险和替代方案.
科学领域:
- 肺部病理学 肺部病理学
- 患者报告的结果
- 药物监督 药物监督 药物监督
背景情况:
- 口服皮质类固醇 (OCS) 对于管理失控喘至关重要,用于恶化和长期维持.
- 虽然医疗保健专业人员 (HCP) 了解OCS不良事件 (AE),但患者的观点往往被低估.
- 本综述侧重于患者在喘和相关呼吸道疾病中使用OCS的经验.
研究的目的:
- 综合并呈现患者对口服皮质类固醇 (OCS) 在喘中的使用的观点.
- 突出患者报告的关键不良事件和对日常生活的影响.
- 探索患者对OCS的看法如何影响治疗坚持.
主要方法:
- 对PubMed进行了全面的文献审查.
- 文章的选择是基于它们对患者在呼吸道疾病中的OCS观点的关注.
- 经过严格的选,包括了14篇相关文章.
主要成果:
- 患者经常报告副作用,如体重增加,皮肤变薄,骨密度问题以及睡眠/情绪障碍.
- OCS显著影响了患者的日常生活和整体幸福感.
- 发现患者对OCS的看法会影响他们对治疗方案的坚持.
结论:
- 医疗人员必须承认并讨论OCS对患者福祉的影响,包括短期使用.
- 在开始治疗之前,对OCS风险和益处进行公开沟通至关重要.
- 建议对长期接受OCS治疗的患者探索替代治疗方法.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
213
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
213
COPD: Management Using Bronchodilators and Corticosteroids
173
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
173
Asthma: Pathogenesis and Management
339
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
339
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications
219
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
219
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231


